image
Enliven Therapeutics, Inc. ELVN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 17.4
-1.88 %
$ 853 M
Market Cap
-8.58
P/E
Price Target Average
115.52%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
--7.23%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Enliven Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for ELVN of $37.5 , with forecasts ranging from a low of $32 to a high of $40 .
ELVN Lowest Price Target Wall Street Target
32 USD 83.91%
ELVN Average Price Target Wall Street Target
37.5 USD 115.52%
ELVN Highest Price Target Wall Street Target
40 USD 129.89%
Price
Max Price Target
Min Price Target
Average Price Target
4040353530302525202015151010Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart ELVN

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ELVN

image
$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ELVN

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029